Close Menu
  • Entertainment
    • Celebrities
    • Music
    • Television & Movies
  • Healthcare
    • Fitness
    • Health
    • Wellbeing
  • Lifestyle
    • Culture
    • Love
    • Trending
  • Living
    • Homes
    • Nice house
  • Style & Beauty
    • Accessories
    • Beauty
    • Fashion
  • Travel
    • Activities
    • Food
    • Places & Attractions
    • Weekend escapes
Facebook X (Twitter) Instagram
Saturday, June 21
  • Homepage
  • Sitemap
Facebook X (Twitter) LinkedIn VKontakte
Healthcare, Lifestyle, Entertainment, Living and TravelHealthcare, Lifestyle, Entertainment, Living and Travel
Banner
  • Entertainment
    • Celebrities
    • Music
    • Television & Movies
  • Healthcare
    • Fitness
    • Health
    • Wellbeing
  • Lifestyle
    • Culture
    • Love
    • Trending
  • Living
    • Homes
    • Nice house
  • Style & Beauty
    • Accessories
    • Beauty
    • Fashion
  • Travel
    • Activities
    • Food
    • Places & Attractions
    • Weekend escapes
Healthcare, Lifestyle, Entertainment, Living and TravelHealthcare, Lifestyle, Entertainment, Living and Travel
Home»Healthcare»Biotech company Scorpius records threefold rise H1 income, secures $14.4M financing
Healthcare

Biotech company Scorpius records threefold rise H1 income, secures $14.4M financing

08/27/20241 Min Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

[ad_1]

Virus Graphs

Eoneren/E+ through Getty Images

  • Biotech company Scorpius Holdings (NYSE:SCPX) CEO Jeff Wolf mentioned on Monday in a letter to shareholders that the company has recorded a threefold enhance in income for the primary half of 2024.
  • Scorpius’ present gross sales pipeline now contains greater than $100M in alternatives throughout the biopharmaceutical and authorities sectors.
  • The company has lately accomplished a spherical of financing, elevating about $14.4M in gross proceeds, Wolf added in his letter.
  • The funds will assist Scorpius to supply higher providers and entice prospects, enabling the biotech company to diversify its buyer base with each business and authorities alternatives.
  • The company has additionally began transitioning a number of of its key shoppers from course of growth part into full-scale manufacturing to allow extra income stream.
  • Shares of Scorpius had been down 3.33% throughout pre-market buying and selling.

More on Scorpius Holdings

[ad_2]

Source: Seekingalpha

14.4M Biotech company financing Records revenue rise Scorpius secures threefold
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleQuest Diagnostics completes LifeLabs acquisition
Next Article MoonLake Immunotherapeutics downgraded on concerns about lack of near-term catalysts

Related Posts

Trump cuts UC health research in DEI purge

04/10/2025

Special needs dentists open more CA clinics with new grants

04/09/2025

How Medicaid cuts would threaten California mental health system- CalMatters

04/08/2025
Latest Posts

≡ The Unspoken Struggles of a Royal Childhood 》 Helitra.com

04/15/2025

Trump cuts UC health research in DEI purge

04/10/2025

Special needs dentists open more CA clinics with new grants

04/09/2025

How Medicaid cuts would threaten California mental health system- CalMatters

04/08/2025

Newsom administration misses Prop. 35 Medi-Cal rate deadline

04/02/2025
Highlights

≡ The Unspoken Struggles of a Royal Childhood 》 Helitra.com

04/15/2025

[ad_1] While many of us dream of being royalty as kids, the truth is that…

Trump cuts UC health research in DEI purge

04/10/2025

Special needs dentists open more CA clinics with new grants

04/09/2025

How Medicaid cuts would threaten California mental health system- CalMatters

04/08/2025
Copyright © 2023. Designed by Helitra.com.
  • Home
  • Entertainment
  • Healthcare
  • Lifestyle
  • Living
  • Style & Beauty
  • Travel

Type above and press Enter to search. Press Esc to cancel.